The Science of HBV Cure Meeting
30 May-2 June, 2022
Hybrid event-Singapour
Âé¶¹ÆÆ½â°æ and its collaborators were presenting the last results on Vonafexor’s effect in HBV at The Science of HBV Cure Meeting organized by Singapore Hepatology Conference.
“Antiviral effects of oral farnesoid X receptor agonist Vonafexor combined with pegylated interferon alpha2a in untreated patients with chronic hepatitis B”.